Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human Primates
Jennifer R. Stapleton-KotloskiiD, Jared A. RowlandiD, April T. DavenportiD, Phillip M. Epperly, Maria W. Blevins, Dwayne W. GodwiniD, Daniel F. EwingiD, Zhaodong Liang, Appavu K. SundaramiD, Nikolai PetrovskyiD, Kevin R. Porter, Christopher S. GambleiD, John W. SandersiD, James B. DaunaisiD
Abstract
SUMMARY PARAGRAPHCOVID-19, caused by the SARS-CoV-2 virus, can lead to widespread neurological complications, including cognitive deficits and neurodegenerative symptoms, even in the absence of significant structural brain abnormalities. The potential neuroprotective effects of SARS-CoV-2 vaccination remain underexplored. Here, we demonstrate the neuroprotective effects of a psoralen-inactivated SARS-CoV-2 vaccine in a non-human primate model using resting-state magnetoencephalography (MEG), a non-invasive neurophysiological recording technique with sub-millisecond temporal and submillimeter spatial resolution. MEG scans demonstrated substantial preservation of neural activity across multiple brain regions in vaccinated subjects compared to unvaccinated controls following viral challenge. This approach not only underscores the role of vaccination in mitigating severe neurological outcomes but also highlights the capability of MEG to detect subtle yet significant changes in brain function that may be overlooked by other imaging modalities. These findings advance our understanding of vaccine-induced neuroprotection and establish MEG as a powerful tool for monitoring brain function in the context of viral infections.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A SARS CoV-2 nucleocapsid vaccine protects against distal viral dissemination
J. Class, T. Dangi, … P. Penaloza-MacMaster·bioRxiv·Apr 26, 2021
- SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta): Monitoring and efficacy
D. Q. P. Oh, I. Grothe, … D. Wegener·bioRxiv·Nov 11, 2022
- SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery
Hailong Li, Kristen A. McLaurin, … Rosemarie M. Booze·Molecular BiomedicinePeer-reviewed·Nov 7, 2023
- Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
K. S. Corbett, M. C. Nason, … Leung·bioRxiv·Apr 20, 2021
- Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
W. Furuyama, K. Shifflett, … A. Marzi·bioRxiv·Jan 19, 2021
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
P. J. M. Brouwer, M. Brinkkemper, … de Bree·bioRxiv·Nov 7, 2020